Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study.
暂无分享,去创建一个
A. Tolcher | C. Takimoto | L. Smith | T. Mays | A. Patnaik | T. Edwards | E. Rowinsky | L. Ochoa | L. Hammond | G. Schwartz | J. D. de Bono | M. DeWitte | R. Chari | J. Lambert | Helen Martino | Z. Jonak | Randall K. Johnson | C. Audette | K. Maes